Navigation Links
Drugs plus Awareness Would Facilitate Reduction of HIV Infection

Rebecca Baggaley of London's Imperial College said that increased access to the AIDS drugs in developing countries could increase HIV infection rates. //

Hence he said that these have to be accompanied by prevention measures, such as patient education. Statistics show that about 95 % of the infected HIV people live in the developing world. This is due to the reason that there is a global push by the World Health Organization to get anti-viral therapy to as many patients as possible. The study was published in the journal Public Library of Medicine. She also said that in the developing countries as they lack recourses the effect would not be that of the desired one.

The resources include counseling patients about how to prevent spreading HIV. This would aid in the WHO campaign against AIDS. To understand the outcomes of anti-viral therapy in poor countries, Baggaley and colleagues developed a model of HIV conditions in Malawi in sub-Saharan Africa. She says even with AIDS drugs administered to them, the model predicts HIV-positive individuals in developing countries are unlikely to do well. The main reason being that they tend to be diagnosed at a late stage in the disease. There is no proper monitoring of the patient’s progression, lack of proper nutrition, fail to take the drugs in a regular basis.

The main goal of antiviral therapy in Malawi and other countries (developing countries) is that more people would l be diagnosed earlier in the course of the disease. This would facilitate in they obtaining the drug at an earlier stage of the disease thereby increasing their life expectancy. But Ms. Baggaley adds that HIV prevalence would increase with antiretroviral therapy. She said that in the United States, widespread use of antiviral drugs led to an increase in unprotected sexual activity among gay HIV-positive men.


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: